BN Business News
Add your company to Business Communicator →

Business · 15/11/1996

FDA Clears Ibuprofen 200-MG Capsule for Approval

The US Food and Drug Administration (FDA) has ruled that ibuprofen (Midol) 200-mg capsules were not removed from the market due to safety or efficacy concerns, paving the way for the approval of generic versions.

Original source language: Federal Register — Food and Drug AdministrationOpen original release →

Explore insights